COVID-19 Updates / 01 September 2020 Edition
1 Sep, 2020 | 03:46h | UTC02 September 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives
Coronavirus Tracked: The Latest Figures
- Coronavirus tracked: the latest figures as the pandemic spreads – Financial Times
- Johns Hopkins Coronavirus Interactive Map
- Coronavirus Map: Tracking the Global Outbreak – The New York Times
- Coronavirus Disease (COVID-19) – Statistics and Research – Our World in Data
- The Covid-19 Tracker – STAT
- WHO: Latest COVID-19 Situation Report – Weekly Epidemiological Update
New #OpenWho Course: Occupational health and safety for health workers in the context of COVID-19
23 bus passengers contracted coronavirus from 1 infected person
- 23 bus passengers contracted coronavirus from 1 infected person. No one was wearing a mask. – Business Insider
- Original Study: Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China – JAMA Internal Medicine
Probable evidence of fecal aerosol transmission of SARS-CoV-2 in a high-rise building
- Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building – Annals of Internal Medicine
- Editorial: SARS-CoV-2: The Growing Case for Potential Transmission in a Building via Wastewater Plumbing Systems
How many people has the coronavirus killed?
Humoral immune response to SARS-CoV-2 in Iceland
- Humoral Immune Response to SARS-CoV-2 in Iceland – New England Journal of Medicine
- Editorial: The Power of Antibody-Based Surveillance
Study: Face shields, masks with valves ineffective against COVID-19 spread
- Face Shields, Masks with Valves Ineffective Against COVID-19 Spread – American Institute of Physics
- Original Study: Visualizing droplet dispersal for face shields and masks with exhalation valves – Physics of Fluids
Meta-analysis: Clinical manifestations, risk factors, and maternal and perinatal outcomes of Covid-19 in pregnancy
Opinion: Managing uncertainty in the Covid-19 era
[Not Published Yet] First randomized trial backs safety of ACE Inhibitors and ARBs in COVID-19 patients
- News Release: First randomised trial backs safety of common heart drugs in COVID-19 patients – European Society of Cardiology
- Commentary: Continuing Versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers – BRACE CORONA – American College of Cardiology
U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine
Perspective: Age in the Age of COVID-19
Selected Articles: